mobile bullet
Facebook Twitter Youtube Instagram
Search
Close
<
National
Global
Metro
Sports
Auto
Entertainment
  • National
  • Global
  • Metro
  • Sports
  • Entertainment
    • Bengali Films
    • Music
    • Bollywood
    • Hollywood
    • Spotlight
    • Movie Reviews
    • Web shows
    • Fashion
    • Food
    • Travel
  • Auto
    • News
    • Previews
    • Test Drives
  • More
    • Business
    • Tech
Menu
  • National
  • Global
  • Metro
  • Sports
  • Entertainment
    • Bengali Films
    • Music
    • Bollywood
    • Hollywood
    • Spotlight
    • Movie Reviews
    • Web shows
    • Fashion
    • Food
    • Travel
  • Auto
    • News
    • Previews
    • Test Drives
  • More
    • Business
    • Tech
Logo-part-1
Logo-part-2New
Facebook Twitter Youtube Instagram
Search
Close
  • National
  • Global
  • Metro
  • Sports
  • Entertainment
    • Bengali Films
    • Music
    • Bollywood
    • Hollywood
    • Spotlight
    • Movie Reviews
    • Web shows
    • Fashion
    • Food
    • Travel
  • Auto
    • News
    • Previews
    • Test Drives
  • More
    • Business
    • Tech
Menu
  • National
  • Global
  • Metro
  • Sports
  • Entertainment
    • Bengali Films
    • Music
    • Bollywood
    • Hollywood
    • Spotlight
    • Movie Reviews
    • Web shows
    • Fashion
    • Food
    • Travel
  • Auto
    • News
    • Previews
    • Test Drives
  • More
    • Business
    • Tech

UK health authorities allow AstraZeneca to resume Covid-19 vaccine trials

The trials were put on hold after a vaccine volunteer reported sick and health authorities informed
Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on whatsapp
Share on skype
Share on email
UNICEF Covid-19 vaccine
also confirmed this was not the first time AstraZeneca said the trial had paused due to safety concerns
  • Bulletin Hours
  • September 12, 2020

AGENCIES, London: The University of Oxford and AstraZeneca Plc have restarted the UK trial of an experimental Covid-19 vaccine after the study was halted over concerns about a volunteer participant who fell ill.

Oxford said in a statement that the UK regulator, the Medicines Health Regulatory Authority (MHRA), had recommended that the trials resume after an independent review of the safety data triggered a pause on Sept. 6

“Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. The UK committee has concluded its investigations and recommended to the MHRA that trials in the U.K. are safe to resume,” AstraZeneca said.

AstraZeneca announced on Wednesday it had “voluntarily paused” its trial of the vaccine developed alongside Oxford University after the volunteer developed an unexplained illness on September 6.

An independent committee was promptly drafted in to review safety, in what the company and the World Health Organization described as a routine step.

AstraZeneca’s vaccine candidate is one of nine around the world currently in late-stage Phase 3 human trials.

The AZD1222 vaccine uses a weakened version of a common cold-causing adenovirus engineered to code for the spike protein that the Covid-19 coronavirus uses to invade cells.After vaccination, this protein is produced inside the human body, which primes the immune system to attack the coronavirus if the person is later infected.

The AstraZeneca product was being considered by subject experts and health authorities like the World Health Organization – to be the leading candidate worldwide.

AstraZeneca’s candidate vaccine is called AZD1222 and was in the final stage of trials before safety and efficacy sign-off data can be submitted to regulators for approval.  Along with Pfizer, and Moderna, AstraZeneca and its partner Oxford University had hoped to know whether the shot worked and was safe by year-end.

 

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on whatsapp
Share on skype
Share on email
PrevPrevious
NextNext

pick of the hour

Aayush Sharma thanks Salman Khan & audience for response to Antim first look

Bulletin Hours December 28, 2020

Had to kill hard in gym: Taapsee Pannu on athletic look in ‘Rashmi Rocket’

Bulletin Hours December 27, 2020
Bollywood

Suresh Raina, Sussanne Khan arrested in raid at Mumbai club

Bulletin Hours December 23, 2020

Ayushmann Khurrana to play Doctor G in new campus comedy

Bulletin Hours December 22, 2020
Bollywood

Seema Pahwa’s directorial debut ‘Ramprasad Ki Tehrvi’ to release on Jan 1

Bulletin Hours December 19, 2020
Sports

Russia banned from Tokyo Olympics, 2022 Beijing Winter Games

Bulletin Hours December 17, 2020

Mamata’s worries mount: Suvendu Adhikari, Jitendra Tiwari quit Trinamool Congress

Bulletin Hours December 17, 2020

Anubhav Sinha’s next to be a creature film set in jungle?

Bulletin Hours December 17, 2020
Bollywood

Ajitpal Singh’s debut Hindi feature, Fire In The Mountains, at Sundance Film Fest

Bulletin Hours December 16, 2020

Rebel TMC leader Suvendu Adhikari likely to join BJP this week in Amit Shah’s presence

Bulletin Hours December 15, 2020

related news

Trump’s H-1B visa ban challenged by 169 NRIs in US court

September 17, 2020 No Comments
new Japan PM Suge

Yoshihide Suga elected by Japan’s parliament as new Prime Minister

September 16, 2020 No Comments
Oracle-TikTok

TikTok sends proposal to US in a bid to allay security fears

September 15, 2020 No Comments
UK PM Boris Johnson

UK crackdown on social rules as Covid-19 fatalities rise

September 9, 2020 No Comments
poor honoured

UK honours Noor Inayat Khan, first Indian-origin WWII spy with blue plaque

August 28, 2020 No Comments
About Us

First the obvious question. In the crowded world of news portals, why another digital onslaught? And how will the just-launched Bulletin Hours be different from the others?

Bulletin Hours comes to you from the pedigree Kolkata-based house that publishes Mahanagar 24X7, a Bengali news portal, three years young that believes in credible and accurate reporting in a world of fake and sensational news, combined with cutting-edge editing, garnished with videos and still images that leave a lasting memory.

Bulletin Hours aims to carry forward that tradition. Led from the front by a team of professionals, we hope to carry forward the tradition of providing incisive and creative content that will impact the real world that we live in. We promise stories that rarely find any place in cyberspace and provide voice to the voiceless. We have planned campaigns that will address reader concerns and hold authorities accountable.

We may be a baby in a world of adults, but there would be nothing flippant about us. Log on to bulletinhours.com from your desktop/laptop/iPad or just follow the news as it breaks on your mobile to get a taste of what we are all about.

Contact Us:

Having some news that you would like to share with us? Get in touch with us at

Email Us:

contactus@bulletinhours.com

Contact Persons:

Office 033 4602 6548

Share on facebook
Share on google
Share on twitter
Share on whatsapp
Share on linkedin
Bulletin Hours © All Right Reserved